发明申请
US20050113576A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
审中-公开
融合的氮杂双环化合物抑制香草素受体亚型1（VR1）受体
- 专利标题： Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
- 专利标题（中）： 融合的氮杂双环化合物抑制香草素受体亚型1（VR1）受体
-
申请号： US10911019申请日： 2004-08-04
-
公开(公告)号： US20050113576A1公开(公告)日： 2005-05-26
- 发明人: Chih-Hung Lee , Erol Bayburt , Stanley DiDomenico , Irene Drizin , Arthur Gomtsyan , John Koenig , Richard Perner , Robert Schmidt , Sean Turner , Tammie Jinkerson , Guo Zheng
- 申请人： Chih-Hung Lee , Erol Bayburt , Stanley DiDomenico , Irene Drizin , Arthur Gomtsyan , John Koenig , Richard Perner , Robert Schmidt , Sean Turner , Tammie Jinkerson , Guo Zheng
- 主分类号： C07D209/08
- IPC分类号： C07D209/08 ; C07D217/02 ; C07D217/22 ; C07D231/56 ; C07D265/30 ; C07D487/08 ; C07D43/02
摘要：
Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.